ReviewClinical reviews in allergy & immunology2008
Wegener's granulomatosis: the current view.
Review in Clinical reviews in allergy & immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS].Der Internist · 2009Guideline
- Prevalence of Psychiatric Disorders among Patients with Granulomatosis with Polyangiitis (Wegener's) and the Predictive Role of Personality Traits.Clinical practice and epidemiology in mental health : CP & EMH · 2024Article
- Sensory-Motor Polyneuropathy and Digital Ischemia: A Rare Presentation of Granulomatosis with Polyangiitis.Case reports in rheumatology · 2021Article
- Top Differential Diagnosis Should Be Microscopic Polyangiitis in ANCA-Positive Patient with Diffuse Pulmonary Hemorrhage and Hemosiderosis.Case reports in pathology · 2014Article
- Altered serum levels of human neutrophil peptides (HNP) and human beta-defensin 2 (hBD2) in Wegener's granulomatosis.Rheumatology international · 2011Article
- Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood.Pediatric nephrology (Berlin, Germany) · 2010Review
- [Anti-B-cell strategies in vasculitides and collagenoses].Zeitschrift fur Rheumatologie · 2009Review
- Successful endonasal dacryocystorhinostomy in a patient with Wegener's granulomatosis.Clinical ophthalmology (Auckland, N.Z.) · 2009Article
- Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?Arthritis research & therapy · 2009Review
- Vasculitis: current status and future directions.Clinical reviews in allergy & immunology · 2008Article
- All Consolidations are not Infective: Look Beyond ARDS.Journal of emergencies, trauma, and shockArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the last few years, substantial progress has been achieved in elucidating the pathogenesis of Wegener's granulomatosis. Several genetic risk factors have been described. The structure of the granuloma and its possible function as ectopic lymphoid tissue have been defined. Furthermore, the consecutive immunopathological reactions leading to induction of PR3-antineutrophil cytoplasmic antibodies (ANCA) and the role of ANCA itself is getting clearer. However, the initial events leading to granuloma formation are still widely unknown. Concerning therapy, the significance of the so-called biological agents (TNF-alpha-blockers, Rituximab) still has to be defined.
Indexed as
Identifiers
18172776What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.